StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Sector-similar peers via Finnhub · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | PGEN PGEN | $4.43 | -3.70% | $1.6B | — | 162.7 | +146.7% | 50.2% | — |
| 1 | RXRX Recursion Pharmaceuticals | $2.94 | -3.29% | $1.6B | — | 23.4 | +11.1% | 7.2% | 55 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $3.46 |
| -1.70% |
| $1.5B |
| — |
| 5.4 |
| +34.3% |
| 36.7% |
| 51 |
| 3 | ARDX Ardelyx | $6.24 | -3.41% | $1.5B | — | 3.6 | +18.2% | 92.5% | 45 |
| 4 | AGIO AGIO | $28.18 | -1.91% | $1.7B | — | 25.4 | +78.3% | 90.0% | — |
| 5 | CAPR CAPR | $28.80 | -3.39% | $1.7B | — | 74.9 | — | — | — |
| 6 | NRIX NRIX | $15.87 | -0.81% | $1.6B | — | 22.8 | +27.2% | — | — |
| 7 | PVLA PVLA | $114.26 | -3.96% | $1.6B | — | 40.0 | -97.2% | — | — |
| 8 | INBX INBX | $108.66 | -6.46% | $1.6B | — | 1133.5 | +550.0% | — | — |
| 9 | GLUE GLUE | $18.16 | -2.78% | $1.5B | — | 35.7 | -73.1% | — | — |